07:40 AM EDT, 05/19/2025 (MT Newswires) -- Teva Pharmaceutical Industries ( TEVA ) said Monday it plans to issue $2 billion equivalent of senior notes through its special purpose finance subsidiaries.

Teva Pharmaceutical Finance Netherlands II intends to offer euro-denominated notes, while Teva Pharmaceutical Finance Netherlands III and Teva Pharmaceutical Finance Netherlands IV aim to offer US dollar-denominated notes.

Separately, the company said it launched cash tender offers for up to $2 billion worth of certain series of notes. The offers are scheduled to expire at 5 pm ET June 17, unless extended or earlier terminated.

Teva said it expects to use the net proceeds from the planned notes issuance, along with cash on hand, to help fund the tender offers, among other things.